International Conference on

Clinical Trials and Clinical Research

Toronto, Canada September 24-26

Clinicaltrials 2018

Meeting International proudly invite all the participants from all over the world to Exchange their Ideas and research in the field of Clinical Trials at International Conference on Clinical Trials and Clinical Research which is going to be held on September 24-26, 2018, Toronto, Canada. This Clinical Trial Conference includes a wide range of Keynote presentations, plenary talks, Symposia, Workshops, Exhibitions, Poster presentations and Career development programs.

Meetings International is a universal ruler in delivering high-quality conferences, meetings, workshops and symposia in all major fields of science, technology and medical. Since its commencement, Meetings International associated with national and international associations, and high-level people, dedicated to hosting world-class conferences and events. It supports broad scope research and peer review at a broad range of specialists around the world. The key strategic goal of Meetings Int. is to communicate science and medical research between academia and industry.

Clinical Trials Conference 2018 aims to bring Scientists, Researchers, Drug developers, Manufacturers on a Global platform to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the results implemented in the field of Clinical trials during the process of drug development. The purpose of Clinical Trials 2018 Conference is to answer scientific questions with scientific standards to produce reliable clinical trials results. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including references of novel research material.

Targeted Audience

Academic People; Scientists, Professors, young researchers, Students, Scientists, Researchers, and Faculty of Medicine and Pharmaceutical Universities, Medical Colleges, Researchers from Pharmaceutical Companies, Pharmacy and Biomedicine Associations and Societies
Business People; Business Entrepreneurs, Training Institutes, Software developing companies, Manufacturing Medical Devices Companies, and Data Management Companies.

Session 1- Clinical Trials and Significance

Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. Clinical trials are essential for the development of new treatments. Clinical trials when well designed, can benefit the participants as well as the investigators, the sponsors, and the medical community.

Session 2- Clinical Trial Phases

The phases of clinical research are the steps in which scientists do experiments with a health intervention in an attempt to find enough evidence for a process which would be useful as a medical treatment. In the case of pharmaceutical study, the phases start with drug design and drug discovery then proceed on to animal testing. If this process is successful, they begin the clinical phase of development by testing for safety in a few human subjects and expand to test in many study participants to determine if the treatment is effective and safe

The Study includes:

Preclinical Studies
Phase I
Phase II
Phase III
Phase IV

Session 3- Design of Clinical Studies and Trials

The objective of clinical trials design is to establish the effect of an intervention. Treatment effects are efficiently isolated by controlling for bias and confounding and by minimizing variation. While designing careful planning with clear foresight is crucial.

Clinical Trial Design includes:

Session 4- Techniques for Improving Clinical Trial Retention

Successful recruitment of patients is known to be one of the most challenging aspects in conduct of randomized controlled trials. Inadequate patient retention during conduct of trial affects the results. Techniques for improving clinical trial recruitment and retention are:

Strategic enrollment planning
Innovative approaches to patient recruitment & retention
Data-driven recruitment and forecasting
Incorporating data and patient insights into enrollment planning
Reaching patients and improving recruitment operations using existing and/or innovative tools
Harnessing the power of digital and social media to drive patient recruitment

Session 5- Clinical Data Management

It is a critical phase in clinical research, which leads to generation of high-quality, reliable, and statistically sound data from clinical trials. Clinical data management assures collection, integration and availability of data at appropriate quality and cost.

Topic includes:

Session 6- Pharmacovigilance & Drug Safety

Pharmacovigilance also known as Drug safety. It is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem. The main purpose of pharmacovigilance is to improve the patient's safety and enhance his care in terms of the use of medicines, including paramedical interventions.

Drug safety can be discussed in different aspects:

Pharmacovigilance in Drug Regulations
Pharmacovigilance and International Health
Adverse Drug Reaction’s

Session 7- Patient Compliance

Patient Compliance is an emerging topic and a matter of concern in clinical research. Patient adherence can apply to several different clinical trial facets which may include a few:

Adherence to study procedures,
Study visit compliance,
Medications and adverse event reporting.

The inception of these risks during a clinical trial can result in not only increasing the cost of clinical trials, but also alters the outcome result.

Session 8- Clinical Research and Bioethics

The study of ethical controversial issues resulting from certain typical situations and new research advancements in field of biology and medicine. It relates the field of medicine, biology, clinical practice and research. It deals with the judgement for various ethical issues that arise in relationships among the fields of life sciences, medicine, law and philosophy.

It includes:

Session 9- Clinical Trial Protocol

The protocol provides information on the background and rationale for a trial and outlines the study plan for that trial. The plan must be carefully designed to safeguard the health and safety of the participants, as well as answer specific research questions. The protocol describes about following procedures

Session 10- Clinical Trials on Different Diseases

Clinical studies are designed on consequent approach of various diseases such as treatment, prevention, diagnosis, screening, genetic and Epidemiological studies of various diseases and few of the diseases are categorised below:

Trials on digestive system and respiratory system diseases
Trials on cardiovascular diseases and devices
Trials on behaviors, mental, eating and sleep disorders
Studies on parasitic, viral, bacterial and fungal diseases
Research and trials on wounds and injuries
Clinical trials on rare diseases

Session 11- Future Perspectives and Innovations in Clinical Studies

Technology enabling patient compliance
Paperless clinical trials
Enforcement of Mobile health technologies in clinical trials
Regenerative medicine
Global collaborative research

Session 12- Clinical Trial Billing

There are three basic clinical research billing scenarios:

Study related clinical services are paid by the study. This could be an industry sponsor, grant, or the department. No clinical services on the study are billed to the research subject or his/her insurer.
Study related clinical services are standard of care and would be provided to the research subject even if not on a clinical research study. These services are typically billed to the research subject or his/her insurer, but can be paid by the study sponsor if contractually agreed upon.
Mixed services. Some of the study related clinical services are standard of care and paid by insurance or the research subject, and some are performed for research purposes only and paid for by the study.

Session 13- Clinical Case Reports

Clinical case reports are key source of evidence in medicine and aim to directly improve global health and convey an important teaching point about a common or important clinical scenario and generate a more expanded search for evidence.

Session 14- Clinical Trials for Medical Devices

Medical devices are approved through the Premarket Approval (PMA) application process and a single confirmatory study is often sufficient for approval. In contrast, drugs are approved through the New Drug Application (NDA) process and drug development is characterized by Phases I through IV clinical trials.

Session 15- Clinical Trials Sponsorship

In the conduct of a clinical trial, a sponsor is an individual, institution, company or organization that takes the responsibility to initiate, manage or finance the clinical trial, but does not actually conduct the investigation. The specific regional requirements for a clinical study sponsor can vary.

The International Conference on Clinical Trials and Clinical Research is to be held at Toronto, Canada during September 24-26, 2018 hosted by Meeting International through the Theme “Contemporary Approaches in Clinical Trials during the Process of Drug Development”. Conference will explore the advances in Clinical Trials, It will be a premier event that brings together a unique and International mix of Experts, Researchers and Decision markers both from Academic and Industry across the globe to exchange their Knowledge, Experience and Research Innovations to build a world Clinical Trials.

Others

The global clinical trials market is expected to reach USD 65.2 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers impacting the market growth are globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution in technology, and boosting demand for CROs to conduct clinical trials.

Globalization of clinical trial has led to increase in investment in new product development in emerging countries thereby, having a positive impact on overall market. The availability of the vast array of services from drug discovery to post-marketing surveillance has further simplified the life for mid-size and small-scale pharmaceutical and biotechnological organizations by providing them the option to outsource what they think is beyond their core expertise. For instance, Pfizer currently has three CROs working with it to enhance its product portfolio and drive innovation.

Phase Outlook (Revenue, USD Million; 2014 - 2025)

Phase I
Phase II
Phase III
Phase IV

Study Design Outlook (Revenue, USD Million; 2014 - 2025)

Interventional
Observational
Expanded Access

Indication Outlook (Revenue, USD Million; 2014 - 2025)

Regional Outlook (Revenue, USD Million; 2014 - 2025)

North America

U.S.

Canada

Europe

Germany

Asia Pacific

China

Japan

Latin America

Mexico

Brazil

South Africa

Why Canada?

Canada captures 4% of global clinical trials, fourth in number of clinical trials sites, and is globally recognized for the quality and expertise of its research clinicians, many of whom are globally recognized for major medical discoveries and innovations, and its ability to conduct clinical research in complex therapeutic areas with diverse population bases.

Canada's competitiveness in clinical trials is also supported by strong government support in public research infrastructure including over $667 million investment by the Canadian Institutes of Health Research (CIHR) in health research funding; as well as a world-class contract research sector with extensive capabilities in phase I-IV clinical trials. Canada's extensive network of academic health institutions and research centres, which support clinical research includes 17 medical schools, approximately 40 groupings of academic healthcare organizations and about 13,600 researchers.